Mesoblast Limited (MESO) launches first cell therapy for children
Recently I’ve put together a list 10 best midcap stocks to buy according to the billionaire. Mesoblast Limited stands one tenth on our list and has launched its first cell therapy for children.
Mesoblast Limited (NASDAQ: MESO) is one of the best intermediate stocks to buy according to a billionaire. Using proprietary mesenchymal lineage cell technology, we are a global leader in the development of allogeneic (off-the-fly) cell drugs. The company targets severe inflammatory diseases that lack effective treatment options. Its lead product, Ryocyl (Remestemcel-L), became FDA-approved mesenchymal stromal cell therapy in March 2025 in children with steroid-resistant acute graft-versus-host disease (GVHD). 1 million lives, including mandatory Medicaid coverage in all states.
Ryocyl currently benefits from the exclusivity and biological exclusivity of orphan drugs for seven years until 2036, and intellectual property protection by 2044 effectively limits competition. This approval identifies the basis for the broader pediatric inflammatory franchise of the business, along with plans to expand the use of Ryoncil to additional pediatric and adult indications.
A medical expert who investigates T-cell immunotherapy.
The company’s manufacturing process allows for consistent, scalable production of cell therapy without the need for donor-recipient matching, easy access and logistics. The company is also promoting other important candidates for Rexlemestrocel-L) who are on track for FDA submissions by the end of 2025 under the RMAT designation.
Although we acknowledge the potential of MESO as an investment, we believe certain AI stocks offer a greater reverse chance, pose a risk of decline. If you’re looking for a highly undervalued AI stock that can make a significant profit from the tariff and supervision trends of the Trump era, check out our free report. Best Short-Term AI Stocks.
Read next: Best and worst dowstock for the next 12 months and 10 unstoppable stocks that can double your money.
Disclosure: None.